Sutro Biopharma, Inc. (STRO) revenue

Revenue · fiscal 2025
$102.48M

Sutro Biopharma, Inc. (STRO) reported revenue of $102.48M in fiscal 2025 (the year ended December 31, 2025). That is 65.2% higher than the $62.04M of fiscal 2024. Figures as of 18 Nov 2026, 03:53 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Revenue, fiscal 2025
$102.48M
Change on fiscal 2024
+65.2%
Growth, 5 years
+19.1% a year
Highest on record
$153.73Mfiscal 2023
Lowest on record
$38.42Mfiscal 2018
Fiscal years on record
102016–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Sutro Biopharma, Inc. revenue, in more detail

Over the five fiscal years to 2025 revenue grew at a compound 19.1% a year. Across the 10 fiscal years on record (2016–2025), the highest was $153.73M in fiscal 2023 and the lowest $38.42M in fiscal 2018.

History · 10 fiscal years

Revenue by fiscal year

Sutro Biopharma, Inc. revenue, year by year

Sutro Biopharma, Inc. (STRO) revenue by fiscal year
Fiscal yearRevenueChangeYear ended
2025$102.48M 65.2% up
2024$62.04M 59.6% down
2023$153.73M 126.8% up
2022$67.77M 9.5% up
2021$61.88M 44.8% up
2020$42.72M 0.0% down
2019$42.74M 11.2% up
2018$38.42M 25.7% down
2017$51.74M 13.4% down
2016$59.73M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

How to read it

Steady growth in revenue is the raw material for everything else; a fall means the company is selling less or charging less.

More on STRO

Sutro Biopharma, Inc., figure by figure

Sutro Biopharma, Inc. (STRO) overview: price, valuation and scorecard

Sutro Biopharma, Inc. revenue: questions and answers

What is Sutro Biopharma, Inc.'s revenue?

Sutro Biopharma, Inc. (STRO) reported revenue of $102.48M in fiscal 2025 (the year ended December 31, 2025). That is 65.2% higher than the $62.04M of fiscal 2024.

What is the growth rate of Sutro Biopharma, Inc.'s revenue?

Over the five fiscal years to 2025 revenue grew at a compound 19.1% a year.

What are the highest and lowest revenue figures on record for Sutro Biopharma, Inc.?

Across the 10 fiscal years on record (2016–2025), the highest was $153.73M in fiscal 2023 and the lowest $38.42M in fiscal 2018.

How is Sutro Biopharma, Inc.'s revenue calculated?

Revenue is everything the company billed its customers over the fiscal year — the top line of its income statement.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Sutro Biopharma, Inc. (STRO) revenue”, data as of 18 November 2026. https://funkfolio.com/stock/STRO/revenue

Underlying data: the company's filings with the SEC and Yahoo Finance.